Evidence map›Paper›PMID 33494787›Full record

ArticleBiotechnology for biofuels2021

Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium funiculosum NCIM1228.

Anmoldeep Randhawa, Nandita Pasari, Tulika Sinha, Mayank Gupta, Anju M Nair, Olusola A Ogunyewo, Sandhya Verma, Praveen Kumar Verma, Syed Shams Yazdani

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Avirulent Isolates ofMicroorganisms · 2023
    Article
  5. Profiling of the β-glucosidases identified in the genome ofApplied and environmental microbiology · 2023
    Article
  6. Article
  7. Heterologous protein production in filamentous fungi.Applied microbiology and biotechnology · 2023
    Review
  8. Genome editing inSTAR protocols · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Anmoldeep RandhawaMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Nandita Pasari *Microbial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Tulika Sinha *Microbial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Mayank GuptaMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Anju M NairMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Olusola A OgunyewoMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Sandhya VermaNational Institute of Plant Genome Research, New Delhi, 110067, India.
Praveen Kumar VermaNational Institute of Plant Genome Research, New Delhi, 110067, India.
Syed Shams YazdaniMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India. shams@icgeb.res.in.ORCID http://orcid.org/0000-0002-6558-4612
Centre for Advanced Bioenergy Research · INInternational Centre for Genetic Engineering and Biotechnology · INNational Institute of Plant Genome Research · INInternational Centre for Genetic Engineering and Biotechnology · ZA

Funding

Department of Biotechnology , Ministry of Science and Technology BT/PR/Centre/03/2011-Phase II
6 · The paper itself

Abstract

backgroundPenicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable traits to be an industrial workhorse, P. funiculosum has been underestimated due to a lack of reliable genetic engineering tools. Tolerance towards common fungal antibiotics had been one of the major hindrances towards development of reliable transformation tools against the non-model fungi. In this study, we sought to understand the mechanism of drug tolerance of P. funiculosum and the provision to counter it. We then attempted to identify a robust method of transformation for genome engineering of this fungus.

resultsPenicillium funiculosum showed a high degree of drug tolerance towards hygromycin, zeocin and nourseothricin, thereby hindering their use as selectable markers to obtain recombinant transformants. Transcriptome analysis suggested a high level expression of efflux pumps belonging to ABC and MFS family, especially when complex carbon was used in growth media. Antibiotic selection medium was optimized using a combination of efflux pump inhibitors and suitable carbon source to prevent drug tolerability. Protoplast-mediated and Agrobacterium-mediated transformation were attempted for identifying efficiencies of linear and circular DNA in performing genetic manipulation. After finding Ti-plasmid-based Agrobacterium-mediated transformation more suitable for P. funiculosum, we improvised the system to achieve random and homologous recombination-based gene integration and deletion, respectively. We found single-copy random integration of the T-DNA cassette and could achieve 60% efficiency in homologous recombination-based gene deletions. A faster, plasmid-free, and protoplast-based CRISPR/Cas9 gene-editing system was also developed for P. funiculosum. To show its utility in P. funiculosum, we deleted the gene coding for the most abundant cellulase Cellobiohydrolase I (CBH1) using a pair of sgRNA directed towards both ends of cbh1 open reading frame. Functional analysis of ∆cbh1 strain revealed its essentiality for the cellulolytic trait of P. funiculosum secretome.

conclusionsIn this study, we addressed drug tolerability of P. funiculosum and developed an optimized toolkit for its genome modification. Hence, we set the foundation for gene function analysis and further genetic improvements of P. funiculosum using both traditional and advanced methods.

Indexed as

Agrobacterium-mediated transformationCellobiohydrolase ICRISPR/Cas9Drug toleranceGenome modification

Identifiers

PMID33494787
PMCPMC7836482
OpenAlexW3122130222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.